Study of carboplatin based combination chemotherapy for good prognosis metastatic malignant teratoma
Completed
- Conditions
- CancerTesticular cancer
- Registration Number
- ISRCTN69711558
- Lead Sponsor
- Medical Research Council (MRC) (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 450
Inclusion Criteria
Histologically confirmed non-seminomatous germ cell tumour of testis or combined seminoma/teratoma or seminoma with unequivocal raised serum alpha feto protein concentration
Exclusion Criteria
Previous chemotherapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complete remission on chemotherapy or chemotherapy + surgery. Progression-free survival. Survival, toxicity.
- Secondary Outcome Measures
Name Time Method ot provided at time of registration